New off-label or compassionate drugs and vaccines in the fight against COVID-19

Luis	 Del Carpio-Orantes

doi:10.54034/mic.e1430

Authors

Luis Del Carpio-Orantes Instituto Mexicano del Seguro Social, Veracruz, Mexico https://orcid.org/0000-0003-2436-5744

DOI:

https://doi.org/10.54034/mic.e1430

Keywords:

COVID-19, tocilizumab, baricitinib, polymerized type I collagen

References

Gordon, A. C., Mouncey, P. R., Al-Beidh, F., Rowan, K. M., Nichol, A. D., Arabi, Y. M., et al. REMAP-CAP Investigators. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Feb 25. DOI: 10.1056/NEJMoa2100433. Epub ahead of print. PMID: 33631065.

Kalil, A. C., Patterson, T. F., Mehta, A. K., Tomashek, K. M., Wolfe, C. R., Ghazaryan, V., et-al. ACTT-2 Study Group Members. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. N Engl J Med. 2020 Dec 11:NEJMoa2031994. DOI: 10.1056/NEJMoa2031994. Epub ahead of print. PMID: 33306283; PMCID: PMC7745180.

Tardif, J. C., Bouabdallaoui, N., L'Allier, P. L., Gaudet, D., Shah, B., Pillinger, M. H., Lopez-Sendon, et-al. Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial. Lancet Respir Med. 2021;9(8):924-932. doi:10.1016/S2213-2600(21)00222-8

Carpio-Orantes LD, García-Méndez S, Martínez-Rojas M, Cortés-Román JS, Jiménez-Flores OR, Pascual-Epigmenio S, et al. Tocilizumab in patients with severe COVID-19 pneumonia in Veracruz, Mexico. J Anesth Crit Care Open Access. 2020;12(5):176-179. DOI: 10.15406/jaccoa.2020.12.00456

Del Carpio-Orantes L, García-Méndez S, Zamudio-Severino GM, Sánchez-Díaz JS, Navarrete-Espinosa B, Rivera-Viñas MÁ, et-al- 498. Baricitinib in Patients with Severe Pneumonia due to COVID-19 in Veracruz, Mexico. Open Forum Infect Dis. 2021 Dec 4;8(Suppl 1):S350–1. doi: 10.1093/ofid/ofab466.697. PMCID: PMC8690645.

Carpio-Orantes LD, García-Méndez S, Sánchez-Díaz JS, Aguilar-Silva A, Contreras-Sánchez ER, Hernández-Hernández SN. Use of Fibroquel® (type I polymerized collagen) in patients with hypoxemic inflammatory pneumonia secondary to COVID-19 in Veracruz, Mexico. J Anesth Crit Care Open Access. 2021;13(1):69‒73. DOI: 10.15406/jaccoa.2021.13.00471

Del Carpio-Orantes L, Márquez-Rodriguez LA, García-Pérez JL, et al. 563. Experience of a Private Hospital in the Treatment of COVID-19 Pneumonia in Veracruz, Mexico. Open Forum Infect Dis. 2021;8(Suppl 1):S383-S384. Published 2021 Dec 4. doi:10.1093/ofid/ofab466.761

Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, et al. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19. N Engl J Med. 2022;386(15):1397-1408. doi:10.1056/NEJMoa2118542

Hager, K. J., Pérez Marc, G., Gobeil, P., Diaz, R. S., Heizer, G., Llapur, C., et al. Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine [published online ahead of print, 2022 May 4]. N Engl J Med. 2022;10.1056/NEJMoa2201300. doi:10.1056/NEJMoa2201300